To know more about the research methodology, drop in an inquiry to speak to our industry experts
Currently: Wegovy, Ozempic, Mounjaro and Zepbound are FDA-approved medications
lectures for Astra-Zeneca, Boehringuer-Ingelnheim, Esteve, Bayer, Eli Lilly and Company, Mundipharma, Astrazeneca, Novartis, Bayer, Astellas and Novo-Nordisk and research activities for Astra-Zeneca
Month 1 Summary: What Was Accomplished Weight loss: 2-4 pounds average (1-2% of starting weight) Appetite change: 60-70% report noticeable suppression Side effects: Mild to moderate in 40% of people, minimal in 60% Discontinuation rate: 3-5% stop during month 1 (lowest attrition period) Psychological state: Hopeful but impatient for faster results Key achievement: Body adapted to medication without major complications Reality check: Month 1 is the easiest month
doi: 10.1016/j.jacbts.2018.09.004 195 Ben-ShlomoSZvibelIShnellMShlomaiAChepurkoEHalpernZet al
Calcium, iron supplements, and some antacids should be separated by at least 2 hours from oral GLP-1 dosing
